Who should not take this medication
AOD9604 is a laboratory research material used to examine cellular and molecular pathways associated with lipid metabolism under controlled experimental conditions
This policy ensures that patients can confidently explore the benefits of B12 injections, knowing they will not incur unnecessary costs if the treatment is unsuitable for their needs
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Vitamin C combines very effectively with vitamin B12 and vitamin H (biotin) injections as part of a comprehensive monthly wellness programme
